Actinic keratosis (AK) is a premalignant skin condition typically seen almost exclusively in Caucasians, due to their fair skin. AKs develop on chronically sun-exposed areas such as the face, the…

Biologic agents are complex protein monoclonal antibodies such as adalimumab and ustekinumab, and genetically engineered recombinant fusion proteins such as etanercept. These agents have added greatly to the therapeutic armamentarium…

INTRODUCTIONHerpes simplex virus (HSV) is the most widely spread virus in the herpes virus family. About one billion people worldwide have been infected with herpes viruses. Orofacial herpes most commonly…

INTRODUCTION Tinea pedis is estimated to be the second most common skin condition in the United States, behind acne. Up to 15% of the population may manifest the disease. 1…

INTRODUCTIONFemale pattern hair loss (FPHL) and androgenetic alopecia are estimated to affect at least 40% of women and 50% of men by the age of 50.1,2 Without intervention, FPHL may…

INTRODUCTION Efinaconazole 10% solution is an antifungal drug that recently completed parallel Phase III clinical trials for the treatment of distal and lateral subungual onychomycosis (DLSO).1 Efinaconazole is a triazole…

INTRODUCTIONErythema and telangiectasias of the face are common clinical findings that affect millions of people worldwide and may be associated with many conditions, including rosacea, photo damage, liver disease, hyperestrogenism,…

INTRODUCTION Hidradenitis suppurativa (HS) is a chronic inflammatory disease of the hair follicle, with an estimated incidence of 0.006%.1 Inflammatory nodules form at apocrine gland–bearing sites of the axilla, groin,…

INTRODUCTIONGood patient adherence is increasingly being recognized as essential to the success of dermatologic treatment regimens. Adherence to dermatologic treatment improves around the time of office visits.1 Visits induce “whitecoat…